Burping is not the most common side effect
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
New England Journal of Medicine , NEJMoa2511774
Further, reduced motivation to obtain sucrose induced by exendin-4 reversed by GLP-1 receptor antagonism, suggesting the effect may be specifically reward-related (Dickson et al
If your brand of choice clearly lists the carnitine form (tartrate, acetyl, propionyl) and provides batch or testing information, that increases your confidence in what you are taking
All these products work by changing the color on just the outer layer of your skin